Raunaq Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 23-06-2024
- Paid Up Capital ₹ 2.50 Cr
as on 23-06-2024
- Company Age 30 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2020)
- Profit 55.56%
(FY 2020)
- Ebitda
- Net Worth -0.03%
(FY 2020)
- Total Assets %
(FY 2020)
About Raunaq Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jay Kothari, Binti Thakur, and Anil Jain serve as directors at the Company.
- CIN/LLPIN
U99999PB1994PLC014099
- Company No.
014099
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Jan 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationPunjab, Punjab
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Raunaq Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jay Kothari  | Director | 21-Apr-2017 | Current |
| Binti Thakur | Director | 27-May-2002 | Current |
| Anil Jain | Director | 01-Sep-2005 | Current |
Financial Performance of Raunaq Laboratories.
Raunaq Laboratories Ltd, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 55.56% increase in profit. The company's net worth dipped by a decrease of 0.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Raunaq Laboratories?
In 2020, Raunaq Laboratories had a promoter holding of 13.36% and a public holding of 86.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Raunaq Laboratories?
Unlock and access historical data on people associated with Raunaq Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raunaq Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raunaq Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
